Alerts will be sent to your verified email
Verify Email
FERVENTSYN
|
Fervent Synergies
|
Remedium Lifecare
|
Astal Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-7.16 % | 38.8 % | 5.65 % |
|
5yr average Equity Multiplier
|
1.01 | 60.3 | 1.45 |
|
5yr Average Asset Turnover Ratio
|
0.33 | 1.25 | 0.4 |
|
5yr Avg Net Profit Margin
|
-11.74 % | 0.65 % | 3.54 % |
|
Price to Book
|
1.74 | 0.85 | 2.13 |
|
P/E
|
25.57 | 41.83 | 9.35 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 478.33 Days | 83.93 Days |
|
Inventory Days
|
0.0 | 78.27 Days | 12.25 Days |
|
Days Receivable
|
0.0 | 694.98 Days | 123.54 Days |
|
Days Payable
|
0.0 | 156.76 Days | 125.63 Days |
|
5yr Average Interest Coverage Ratio
|
303.36 | 9.58 | 21.93 |
|
5yr Avg ROCE
|
-6.97 % | 66.83 % | 7.95 % |
|
5yr Avg Operating Profit Margin
|
-8.29 % | 0.73 % | 4.11 % |
|
5 yr average Debt to Equity
|
0.0 | 6.84 | 0.08 |
|
5yr CAGR Net Profit
|
76.96 % | 14.55 % | 289.2 % |
|
5yr Average Return on Assets
|
-7.13 % | 0.69 % | 3.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.75 % | 1.13 % | 18.19 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
4.19 % | 0.02 % | -49.99 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fervent Synergies
|
Remedium Lifecare
|
Astal Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|